Abstract
Reflecting on the past three years and the coronavirus disease 19 (COVID-19) pandemic, varying global tactics offer insights into the most effective public-health responses. In the US, specifically, rapid and widespread testing was quickly prioritized to lower restrictions sooner. Essentially, only two types of COVID-19 diagnostic tests were publicly employed during the peak pandemic: the rapid antigen test and reverse transcription polymerase chain reaction (RT-PCR). However, neither test ideally suited the situation, as rapid antigen tests are far too inaccurate, and RT-PCR tests require skilled personnel and sophisticated equipment, leading to long wait times. Loop-mediated isothermal amplification (LAMP) is another exceptionally accurate nucleic acid amplification test (NAAT) that offers far quicker time to results. However, RT-LAMP COVID-19 tests have not been embraced as extensively as rapid antigen tests or RT-PCR. This review will investigate the performance of current RT-LAMP-based COVID-19 tests and summarize the reasons behind the hesitancy to embrace RT-LAMP instead of RT-PCR. We will also look at other LAMP platforms to explore possible improvements in the accuracy and portability of LAMP, which could be applied to COVID-19 diagnostics and future public-health outbreaks.
Original language | English (US) |
---|---|
Article number | 492 |
Journal | Biosensors |
Volume | 12 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2022 |
Keywords
- RT-LAMP
- RT-PCR
- SARS-CoV-2
- loop-mediated isothermal amplification
- nucleic acid amplification test (NAAT)
- rapid antigen test
ASJC Scopus subject areas
- Analytical Chemistry
- Biotechnology
- Biomedical Engineering
- Instrumentation
- Engineering (miscellaneous)
- Clinical Biochemistry